
Palatin Technologies PTN
$ 20.35
-1.45%
Quarterly report 2025-Q4
added 02-17-2026
Palatin Technologies P/E Ratio 2011-2026 | PTN
Annual P/E Ratio Palatin Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.00483 | -0.0107 | -0.68 | -1.78 | - | -6.17 | 5.4 | 7.62 | -5.8 | -2.45 | -6.64 | -7.66 | -3.18 | -1.31 | -1.65 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.62 | -7.66 | -1.74 |
P/E Ratio of other stocks in the Biotechnology industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Ultragenyx Pharmaceutical
RARE
|
-3.5 | $ 19.23 | -3.85 % | $ 1.9 B | ||
|
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | ||
|
RedHill Biopharma Ltd.
RDHL
|
-12.3 | $ 0.8 | 0.89 % | $ 428 M | ||
|
Dr. Reddy's Laboratories Limited
RDY
|
0.625 | $ 13.56 | -1.56 % | $ 2.25 B | ||
|
Regeneron Pharmaceuticals
REGN
|
18 | $ 742.02 | -1.94 % | $ 77.6 B | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | ||
|
Replimune Group
REPL
|
-2.43 | $ 7.22 | -4.24 % | $ 582 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
REGENXBIO
RGNX
|
-2.29 | $ 7.88 | -4.6 % | $ 406 M | ||
|
Aileron Therapeutics
ALRN
|
-0.608 | - | 10.36 % | $ 9.8 M | ||
|
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Arena Pharmaceuticals
ARNA
|
-9.16 | - | -6.81 % | $ 3.04 B | ||
|
Rigel Pharmaceuticals
RIGL
|
1.63 | $ 26.2 | -0.64 % | $ 471 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0465 | - | -52.27 % | $ 4.45 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
Atreca
BCEL
|
-0.504 | - | -11.76 % | $ 5.79 M | ||
|
Avidity Biosciences
RNA
|
-14.7 | $ 13.09 | -0.08 % | $ 1.8 B | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
-0.316 | - | - | $ 546 M | ||
|
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Avid Bioservices
CDMO
|
-3.01 | - | - | $ 789 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
Rhythm Pharmaceuticals
RYTM
|
-32.3 | $ 78.52 | -4.13 % | $ 5.1 B | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
-41.7 | $ 12.57 | -9.96 % | $ 1.91 B | ||
|
Sana Biotechnology
SANA
|
-4.08 | $ 2.78 | -8.42 % | $ 704 M | ||
|
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B | ||
|
SIGA Technologies
SIGA
|
17.4 | $ 5.35 | 7.76 % | $ 383 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
130 | $ 321.71 | -1.96 % | $ 42.1 B | ||
|
BioDelivery Sciences International
BDSI
|
3.63 | - | -4.8 % | $ 255 M | ||
|
Cara Therapeutics
CARA
|
-0.457 | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
-0.0138 | - | - | $ 3.74 B | ||
|
Silence Therapeutics plc
SLN
|
-41.3 | $ 4.8 | -9.6 % | $ 622 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-1.22 | $ 1.08 | -0.92 % | $ 22.2 M | ||
|
Enochian Biosciences
ENOB
|
-0.649 | - | - | $ 40.5 M |